Investing Profile

Christina Isacson

InvestorVC
Partner at Lightstone Ventures
Photo of Christina Isacson, Partner at Lightstone Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
McGill University Network
141 CONNECTIONS
Third Rock Ventures Network
50 CONNECTIONS
BU Today Network
14 CONNECTIONS
cb
$100K - $5.0M
$1.5M
2
$250M
CompanyStageDateRound SizeTotal Raised
PsiThera
Series ADec 2025$48M
$48M
Co-investors: Srini Akkaraju (Samsara BioCapital)
Tagworks Pharmaceuticals
Series AJun 2023$65M
$65M
Co-investors: Michele Park (Clarus Ventures), Marianne Uteng (Novartis Venture Fund)
Consultant AcceleratorPresent
Manager, New Ventures BU TodayPresent
Associate Director, Business Development Ironwood PharmaceuticalsPresent
Director, Business Development Ironwood PharmaceuticalsPresent
Senior Director Business Development Ironwood PharmaceuticalsPresent
Principal Third Rock VenturesPresent
Head of Business Development & Strategy Decibel TherapeuticsPresent
Interim Head of Business Development & Strategy Decibel TherapeuticsPresent
Head of Business Development & Strategy Edimer PharmaceuticalsPresent
Vice President & Head of Business Development Magenta TherapeuticsPresent
Vice President & Head of Business Development Edimer PharmaceuticalsPresent
Chief Business Officer Magenta TherapeuticsPresent
Chief Business Officer Edimer PharmaceuticalsPresent
Member Board of Directors Bonito BiosciencesPresent
Advisory Committee Member Edimer PharmaceuticalsPresent
Member Board of Directors Tagworks PharmaceuticalsPresent
Member Board of Directors Atsena TherapeuticsPresent
Chair & Member Board of Directors PsiTheraPresent
Partner Lightstone VenturesPresent
McGill University BSc. Biology/Business
Tufts University School of Medicine Ph.D. Neuroscience
Sign in with Google →
Sign in with Google →